glp 1 accessibility Discover How GLP-1 Trials Are Not One-Size-Fit-All Accessibility to GLP-1 Agonists" |

The dual action on diabetes and obesity has now positioned GLP-1 agonists in a prominent position for addressing two of the most pressing health challenges of this generation (Chothave et al., 2024)

Once released, GLP-1 can act locally within the intestine or enter the central nervous system to regulate various physiological processes throughout the body [6]

M2 macrophages are anti-inflammatory, promoting tissue repair and resolution of inflammation

-Carrageenan exhibits antiviral properties, making it a candidate for nasal sprays, but its limited spray coverage and poor mucoadhesion restrict its effectiveness 26